Chapter 11 Neurotrophic Factors and the Aging Brain

Advances in Cell Aging and Gerontology

Volumn 2, Issue C, 1997, Pages 299-345

  Mattson, Mark P ^a   Lindvall, Olle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956813083     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(08)60061-9     Document Type: Article

References (263)

1. Abe K., Tanzi R.E., and Kogure K. Selective induction of kunitz-type inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125 (1991) 172-174
2. Aebischer P., Schluep M., Deglon N., Joseph J.M., Hirt L., Heyd B., Goddard M., Hammang J.P., Zurn A.D., Kato A.C., Regli F., and Baetge E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2 (1996) 696-699
3. Aguilar L.C., Islas A., Rosique P., Hernandez B., Portillo E., Herrera J.M., Cortes R., Cruz S., Alfaro F., and Martin R. Psychometric analysis in children with mental retardation due to perinatal hypoxia treated with fibroblast growth factor (FGF). & showing improvement in mental development. J. Intellect. Disabil. Res. 37 (1993) 507-520
4. ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF). in amyotrophic lateral sclerosis. Neurology 46 (1996) 1244-1249
5. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90 (1993) 7915-7922
6. Anderson K.D., Panayotatos N., Corcoran T.L., Lindsay R.M., and Wiegand S.J. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc. Natl. Acad. Sci. USA 93 (1996) 7346-7351
7. Araki W., Kitaguchi N., Tokushima Y., Ishii K., Aratake H., Shimohama S., Nakamura S., and Kimura J. Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture. Biochem. Biophys. Res. Commun. 181 (1991) 265-271
8. Arenas E., and Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367 (1994) 368-371
9. Arenas E., Trupp M., Åkerud P., and Ibañez C.F. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15 (1995) 1465-1473
10. Ballarin M., Ernfors P., Lindefors N., and Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in mRNA for BDNF and NGF in the rat brain. Exp. Neurol. 114 (1991) 35-43
11. Barbacid M. Neurotrophic factors and their receptors. Curr. Opin. Cell Biol. 7 (1995) 148-155
12. Barde Y.A. Neurotrophins: a family of proteins supporting the survival of neurons. Prog. Clin. Biol. Res. 390 (1994) 45-56
13. Barger S.W., and Mattson M.P. Secreted form of the Alzheimer's β-amyloid precursor induces neuroprotective KB-dependent transcription. Mol. Brain Res. 40 (1996) 116-126
14. Barger S.W., and Mattson M.P. Secreted form of the Alzheimer's amyloid precursor protein stimulates a membrane-associated guanylate cyclase. Biochem. J. 311 (1995) 45-47
15. 2+ accumulation. Proc. Natl. Acad. Sci. USA. 92 (1995) 9328-9332
16. Barger S.W., Fiscus R.R., Ruth P., Hofmann F., and Mattson M.P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β amyloid precursor. J. Neurochem. 64 (1995) 2087-2096
17. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
18. Beck K.D., Knusel B., and Hefti F. The nature of the trophic action of brain-derived neurotrophic factor, des(1--3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 52 (1993) 855-866
19. Beck T., Lindholm D., Castren E., and Wree A. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14 (1994) 689-692
20. Beck K., Valerde J., Alexi T., Poulsen K., Moffat B., Vandlen R., Rosenthal A., and Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373 (1995) 339-341
21. Behl C., Davis J., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1994) 817-827
22. Behl C., Widmann M., Trapp T., and Holsboer F. 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216 (1995) 473-482
23. Benzi G., and Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol. Aging 16 (1995) 661-674
24. Beyreuther K., Pollwein P., Multhaup G., Monning U., Konig G., Dyrks T., Schubert W., and Masters C.L. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann. N. Y. Acad. Sci. 695 (1993) 91-102
25. Bondy C., Werner H., Roberts Jr. C.T., and LeRoith D. Cellular pattern of type-1 insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors 1 and 2. Neuroscience. 46 (1992) 909-923
26. Bowling A.C., and Beal M.F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56 (1995) 1151-1171
27. Brown Jr. R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80 (1995) 687-692
28. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., and Mattson M.P. Altered neuronal and microglial responses to brain injury in mice lacking TNF receptors. Nature Medicine 2 (1996) 788-794
29. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm-Matthaei R., Baeuerle P.A., and Barde Y.A. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272 (1996) 542-545
30. Cass W.A., Kearns C.M., and Gash D.M. Protective and regenerative properties of GDNF in the central nervous system. In: Mattson M.P. (Ed). Neuroprotective Signal Transduction (1997), Humana Press, Totowa, NJ. in press
31. Castren E., Zafra F., Thoenen H., and Lindholm D. Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. Proc. Natl. Acad. Sci. USA 89 (1992) 9444-9448
32. Castren E., Pitkanen M., Sirvio J., Parsadanian A., Lindholm D., Thoenen H., and Riekkinen P.J. The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus. NeuroReport 4 (1993) 895-898
33. Chao M.V. Neurotrophin receptors: a window into neuronal differentiation. Neuron 9 (1992) 583-593
34. Chao C.C., Hu S., Kravitz F.H., Tsang M., Anderson W.R., and Peterson P.K. Transforming growth factor-β protects human neurons against beta-amyloid-induced injury. Mol. Chem. Neuropathol. 23 (1994) 159-178
35. Chen K.S., and Gage F.H. Somatic gene transfer of NGF to the aged brain: behavioural and morphological amelioration. J. Neurosci. 15 (1995) 2819-2825
36. Chen K.S., Masliah E., Mallory M., and Gage F.H. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 68 (1995) 19-27
37. Cheng B., and Mattson M.P. NGF and bFGF protect rat and human central neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 7 (1991) 1031-1041
38. Cheng B., and Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12 (1992) 1558-1566
39. Cheng B., and Mattson M.P. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF. Exp. Neurol. 117 (1992) 114-123
40. Cheng B., and Mattson M.P. NT-3 and BDNF protect hippocampal, septal, and cortical neurons against metabolic compromise. Brain Res. 640 (1994) 56-67
41. Cheng B., and Mattson M.P. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J. Neurosci. 15 (1995) 7095-7104
42. Cheng B., Christakos S., and Mattson M.P. Tumor necrosis factors protect neurons against excitotoxic/metabolic insults and promote maintenance of calcium homeostasis. Neuron 12 (1994) 139-153
43. Cheng B., Goodman Y., Begley J.G., and Mattson M.P. Neurotrophin 4/5 protects hippocampal and cortical neurons against energy deprivation- and excitatory amino acid-induced injury. Brain Res. 650 (1994) 331-335
44. 2+ responses to AMPA and NMDA in hippocampal neurons. J. Neurochem. 65 (1995) 2525-2536
45. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
46. Collazo D., Takahashi H., and McKay R.D.G. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron 9 (1992) 643-656
47. Crutcher K.A., and Weingartner J. Hippocampal NGF levels are not reduced in the aged Fischer 344 rat. Neurobiol. Aging 12 (1991) 449-454
48. Cummings B.J., Su J.H., and Cotman C.W. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp. Neurol. 124 (1993) 315-325
49. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind J.S., and Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381 (1996) 800-803
50. Davies K.J. Oxidative stress: the paradox of aerobic life. Biochem. Soc. Symp. 61 (1995) 1-31
51. de Belleroche J., Orrell R., and King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J. Med. Genet. 32 (1995) 841-847
52. Derynck R. TGF-β-receptor-mediated signaling. Trends Biochem. Sci. 19 (1994) 548-553
53. Dobrowsky R.T., Wemer M.H., Castellino A.M., Chao M.V., and Hannun Y.A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265 (1994) 1596-1599
54. Dragunow M., Beilharz E., Mason B., Lawlor P., Abraham W., and Gluckman P. Brain-derived neurotrophic factor expression after long-term potentiation. Neurosci. Lett. 160 (1993) 232-236
55. Elliott E., Mattson M.P., Vanderklish P., Lynch G., Chang I., and Sapolsky R.M. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61 (1993) 57-67
56. Emerich D.F., Hammang J.P., Baetge E.E., and Winn S.R. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130 (1994) 141-150
57. Emerich D.F., Lindner M.D., Winn S.R., Chen E.Y., Frydel B.R., and Kordower J.H. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16 (1996) 5168-5181
58. Falkenberg T., Mohammed A.K., Henriksson B., Persson H., Winblad B., and Lindefors N. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci. Lett. 138 (1992) 153-156
59. Fallon J.H., Annis C.M., Gentry L.E., Twardzik D.R., and Loughlin S.E. Localization of cells containing transforming growth factor alpha precursor immunoreactivity in the basal ganglia of the adult rat brain. Growth Factor 2 (1990) 241-250
60. Festoff B.W., Yang S.X., Vaught J., Bryan C., and Ma J.Y. The insulin-like growth factor signaling system and ALS neurotrophic factor treatment strategies. J. Neurol. Sci. 129 (1995) 114-121
61. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., and Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381 (1996) 706-709
62. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., and Pasinetti G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53 (1993) 314-322
63. Finklestein S.P., Apostolides P.J., Daday C.G., Prosser J., Phillips M.G., and Klagsbrun M. Increased basic fibroblast growth factor (bFGF). immunoreactivity at the site of focal brain wounds. Brain Res. 460 (1988) 253-259
64. Finklestein S.P. Preclinical trials of bFGF in animal models of stroke. In: Mattson M.P. (Ed). Neuroprotective Signal Transduction (1997), Humana Press, Totowa, NJ. in press
65. Fischer W., Wictorin K., Björklund A., Williams L.R., Varon S., and Gage F.H. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329 (1987) 65-68
66. Fischer W., Björklund A., Chen K.S., and Gage F.H. NGF improves spatial memory in aged rodents as a function of age. J. Neurosci. 11 (1991) 1889-1906
67. Fischer W., Sirevaag A., Wiegand S.J., Lindsay R.M., and Björklund A. Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA. 91 (1994) 8607-8611
68. Fornai F., Vaglini F., Maggio R., Bonuccelli U., and Corsini G.U. Excitatory amino acids and MPTP toxicity. Adv. Neurol. 69 (1996) 167-176
69. Freese A., Finklestein S.P., and DiFiglia M. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA receptor-mediated excitotoxicity. Brain Res. 575 (1992) 351-355
70. Frim M.D., Short P.M., Rosenberg S.W., Simpson J., Breakfield X.O., and Isacson O. Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J. Neurosurg. 78 (1993) 267-273
71. Frim D.M., Simpson J., Uhler T.A., Short M.P., Bossi S.R., Breakefield X.O., and Isacson O. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35 (1993) 452-458
72. Frim D.M., Uhler T.A., Galpern W.R., Beal M.F., Breakefield X.O., and Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA. 91 (1994) 5104-5108
73. Frim D.M., Wullner U., Beal M.F., and Isacson O. Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp. Neurol. 128 (1994) 172-180
74. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379 (1996) 74-78
75. Gage F.H., Wictorin K., Fischer W., Williams L.R., Varon S., and Björklund A. Life and death of cholinergic neurons in the septal and diagonal band region following complete fimbria-fornix transection. Neruroscience 19 (1986) 241-255
76. Gallagher M., and Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol. 5 (1995) 161-168
77. Games D., Adams D., Alessandrinl R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Lelbowitz E., McConlogue S., Montoya-Zavalal M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373 (1995) 523-527
78. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., and Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380 (1996) 252-255
79. Gluckman P., Klempt N., Guan J., Mallard C., Sirimanne E., Dragunow M., Klempt M., Singh K., Williams C., and Nikolics K. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182 (1992) 593-599
80. Goodman Y., and Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128 (1994) 1-12
81. Goodman Y., and Mattson M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66 (1996) 869-872
82. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res. 706 (1996) 328-332
83. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
84. Greenberg S.M., Koo E.H., Selkoe D.J., Qiu W.Q., and Kosik K.S. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc. Natl. Acad. Sci. USA 91 (1994) 7104-7108
85. Griffin W.S., Sheng J.G., Roberts G.W., and Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54 (1995) 276-281
86. Gross C.E., Bednar M.M., Howard D.B., and Sporn M.B. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24 (1993) 558-562
87. Guan K.L. The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell. Signal 6 (1994) 581-589
88. Guo Q., Sopher B.L., Pham D.G., Furukawa K., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17 (1997) 4212-4222
89. Gusella J.F., and MacDonald M.E. Huntington's disease: CAG genetics expands neurobiology. Curr. Opin. Neurobiol. 5 (1995) 656-662
90. Hara H., Onodera H., Yoshidomi M., Matsuda Y., and Kogure K. Staurosporine, a novel protein kinase C inhibitor, prevents post-ischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow Metab. 10 (1990) 646-653
91. Hashimoto Y., Kawatsura H., Shiga Y., Furukawa S., and Shigeno T. Significance of nerve growth factor content levels after transient forebrain ischemia in gerbils. Neurosci. Lett. 139 (1992) 45-46
92. Hatzinger M., Z'Brun A., Hemmeter U., Seifritz E., Baumann F., Holsboer-Trachsler E., and Heuser I.J. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol. Aging 16 (1995) 205-209
93. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6 (1986) 2155-2162
94. Hefti F., and Mash D.C. Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease. Neurobiol. Aging 10 (1989) 75-87
95. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., and Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51 (1994) 896-900
96. Heumann R. Neurotrophin signalling. Curr. Opin. Neurobiol. 4 (1994) 668-679
97. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., and Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182 (1994) 107-111
98. Holtzman D.M., Li Y., Chen K., Gage F.H., Epstein C.J., and Mobley W.C. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology 43 (1993) 2668-2673
99. Hull M., Berger M., Volk B., and Bauer J. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Ann. N. Y. Acad. Sci. 777 (1996) 205-212
100. Hutchins J.B., and Jefferson V.E. Developmental distribution of platelet-derived growth factor in the mouse central nervous system. Dev. Brain Res. 67 (1992) 121-135
101. Iihara K., Sasahara M., Hashimoto N., Uemura Y., Kikuchi H., and Hazama F. Ischemia induces the expression of the platelet-derived growth factor-B chain in neurons and brain macrophages in vivo. J. Cereb. Blood Flow Metab. 14 (1994) 818-824
102. Ip N.Y., Li Y., Yancopoulos G.D., and Lindsay R.M. Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF. J. Neurosci. 13 (1993) 3394-3405
103. Isackson P.J. Trophic factor response to neuronal stimuli or injury. Curr. Opin. Neurobiol. 5 (1995) 350-357
104. Ishida A., Furukawa K., Keller J.N., and Mattson M.P. Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport 8 (1997) 2133-2137
105. Jacque C., and Tchelingerian J.L. New concepts on the role of cytokines in the central nervous system. Rev. Neurol. (Paris) 150 (1994) 748-756
106. Jope R.S. Cholinergic muscrinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alsz. Dis. Rev. 1 (1996) 2-14
107. Kang H.J., and Schuman E.M. Neurotrophin-induced modulation of synaptic transmission in the adult hippocampus. J. Physiol. Paris 89 (1995) 11-22
108. Kelly J., Furukawa K., Barger S.W., Mark R.J., Rengen M.R., Blanc E.M., Roth G.S., and Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in coritcal neurons. Proc. Natl. Acad. Sci. USA 93 (1996) 6753-6758
109. Kimura H., Tooyama I., and McGeer P.L. Acidic FGF expression in the surroundings of senile plaques. Tohoku J. Exp. Med. 174 (1994) 279-293
110. Kinouchi K., Brown G., Pasternak G., and Donner D.B. Identification and characterization of receptors for tumor necrosis factor-α in the brain. Biochem. Biophys. Res. Commun. 181 (1991) 1532-1538
111. Kiyota Y., Takami K., Iwane M., Shino A., Miyamoto M., Tsukuda R., and Nagaoka A. Increase in basic fibroblast growth factor-like immunoreactivity in rat brain after forebrain ischemia. Brain Res. 545 (1991) 322-328
112. Klempt N.D., Sirimanne E., Gunn A.J., Klempt M., Singh K., Williams C., and Gluckman P.D. Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain. Mol. Brain Res. 13 (1992) 93-101
113. Knusel B., and Gao H. Neurotrophins and Alzheimer's disease: beyond the cholinergic neurons. Life Sci. 58 (1996) 2019-2027
114. Knusel B., Burton L.E., Longo F.M., Mobley W.C., Koliatsos V.E., Price D.L., and Hefti F. Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cells. Exp. Neurol. 110 (1990) 274-283
115. Koh S., Chang P., Collier T.J., and Loy R. Loss of NGF receptor immunoreactivity in basal forebrain neurons of aged rats: correlation with spatial memory impairment. Brain Res. 498 (1989) 397-404
116. Koh J., Yang L.L., and Cotman C.W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533 (1990) 315-320
117. Kokaia Z., Othberg A., Kokaia M., and Lindvall O. BDNF makes cultured dentate granule cells more resistant to hypoglycaemic damage. NeuroReport 5 (1994) 1241-1244
118. Kokaia Z., Metsis M., Kokaia M., Elmer E., and Lindvall O. Co-expression of TrkB and TrkC receptors in CNS neurons suggests regulation by multiple neurotrophins. NeuroReport 6 (1995) 769-772
119. Kokaia Z., Zhao Q., Kokaia M., Elmér E., Metsis M., Smith M.-L., Siesjö B.K., and Lindvall O. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp. Neurol. 136 (1995) 73-88
120. Koketsu N., Berlove D.J., Moskowitz M.A., Kowall N.W., Caday C.G., and Finklestein S.P. Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann. Neurol. 35 (1994) 451-457
121. Kolesnick R., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
122. Koliatsos V.E., Clatterbuck R.E., Winslow J.W., Cayouette M.H., and Price D.L. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 10 (1993) 359-367
123. Kordower J.H., Winn S.R., Liu Y.T., Mufson E.J., Sladek J.R., Hammang J.P., Baetge E.E., and Emerich D.F. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. USA. 91 (1994) 10898-10902
124. Kordower J.H., Charles V., Bayer R., Bartus R.T., Putney S., Walus L.R., and Friden P.M. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc. Natl. Acad. Sci. USA. 91 (1994) 9077-9080
125. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., and Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92 (1995) 8856-8860
126. Lane M.A., Baer D.J., Rumpler W.V., Weindruch R., Ingram D.K., Tilmont E.M., Cutler R.G., and Roth G.S. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc. Natl. Acad. Sci. USA 93 (1996) 4159-4164
127. Lapchak P.A., Araujo D.M., Beck K.D., Finch C.E., Johnson S.A., and Hefti F. BDNF and trkB mRNA expression in the hippocampal formation of aging rats. Neurobiol. Aging 14 (1993) 121-126
128. Lärkfors L., Ebendal T., Whittemore S.R., Persson H., Hoffer B., and Olson L. Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Mol. Brain Res. 3 (1987) 55-60
129. Lee W.-H., Clemens J.A., and Bondy C.A. Insulin-like growth factors in the response to cerebral ischemia. Mol. Cell. Neurosci. 3 (1992) 36-43
130. Lee T.H., Abe K., Kogure K., and Itoyama Y. Expressions of nerve growth factor and p75 low affinity receptor after transient forebrain ischemia in gerbil hippocampal CA1 neurons. J. Neurosci. Res. 41 (1995) 684-695
131. Lessmann V., Gottmann K., and Heumann R. BDNF and NT-4/5 enhance glutamatergic synaptic transmission in cultured hippocampal neurones. NeuroReport 6 (1994) 21-25
132. Levi-Montalcini R., Dal Toso R., della Valle F., Skaper S.D., and Leon A. Update of the NGF saga. J. Neurol. Sci. 130 (1995) 119-127
133. Levine E.S., Dreyfus C.F., Black I.R., and Plummer M.R. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc. Natl. Acad. Sci. USA 92 (1995) 8074-8077
134. Levivier M., Przedborski S., Bencsics C., and Kang U.J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15 (1995) 7810-7820
135. Li L., Wu W., Lin L.F., Lei M., Oppenheim R.W., and Houenou L.J. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92 (1995) 9771-9775
136. Lindholm D., Castren E., Kiefer R., Zafra F., and Thoenen H. Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117 (1992) 395-400
137. Lindner M.D., Kearns C.E., Winn S.R., Frydel B., and Emerich D.F. Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transplant 5 (1996) 205-223
138. Lindsay R.M. Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Loughlin S.E., and Fallon J.H. (Eds). Neurotrophic Factors (1993), Academic Press, San Diego 257-284
139. Lindvall O. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. USA. 89 (1992) 648-652
140. Lindvall O., Kokaia Z., Bengzon J., Elmer E., and Kokaia M. Neurotrophins and brain insults. Trends Neurosci. 17 (1994) 490-496
141. Liu T., Clark R.K., McDonnell P.C., Young P.R., White M.S., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke 25 (1994) 1481-1488
142. Longo R.M., Holtzman D.M., Grimes M.L., and Mobley W.C. Nerve growth factor: actions in the peripheral and central nervous systems. In: Loughlin S.E., and Fallon J.H. (Eds). Neurotrophic Factors. (1993), Academic Press, San Diego 209-256
143. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 (1995) 7929-7939
144. 2+ homeostasis and cell death. J. Neurosci. 15 (1995) 6239-6249
145. Mark R.J., Pang Z., Geddes J.W., Uchida K., and Mattson M.P. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17 (1997) 1046-1054
146. +-ATPase activity in hippocampal neurons. Brain Res. 756 (1997) 205-214
147. Markowska A.L., Koliatsos V.E., Breckler S.J., Price D.L., and Olton D.S. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 14 (1994) 4815-4824
148. Markowska A.L., Price D., and Koliatsos V.E. Selective effects of nerve growth factor on spatial recent memory as assessed by a delayed nonmatching-to-position task in the water maze. J. Neurosci. 16 (1996) 3541-3548
149. Martínez-Serrano A., Fischer W., and Björklund A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15 (1995) 473-484
150. Martínez-Serrano A., and Björklund A. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J. Neurosci. 16 (1996) 4604-4616
151. Martínez-Serrano A., Fischer W., Söderström S., Ebendal T., and Björklund A. Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebain. Proc. Natl. Acad. Sci. USA 93 (1996) 6355-6360
152. Mattson M.P. Cellular signaling mechanisms common to the development and degeneration of neuroarchitecture. Mech. Aging Dev. 50 (1989) 103-157
153. Mattson M.P. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4 (1990) 105-117
154. Mattson M.P. β-amyloid precursor protein metabolites, metabolic compromise, and loss of neuronal calcium homeostasis in Alzheimer's disease. Ann. N. Y. Acad. Sci. 747 (1995) 50-76
155. Mattson M.P., and Scheff S.W. Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapies. J. Neurotrauma 11 (1994) 3-33
156. Mattson M.P., and Furukawa K. Programmed cell life: anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders. Restorative Neural. Neurosci. 9 (1996) 191-205
157. Mattson M.P., and Mark R.J. Excitotoxicity and excitoprotection in vitro. Adv. Neurol. 71 (1996) 1-37
158. Mattson M.P., Murrain M., Guthrie P.B., and Kater S.B. Fibroblast growth factor and glutamate: Opposing actions in the generation and degeneration of hippocampal neuroarchitecture. J. Neurosci. 9 (1989) 3728-3740
159. Mattson M.P., Engle M.G., and Rychlik B. Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cerebral cortical neurons. Mol. Chem. Neuropathol. 15 (1991) 117-142
160. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
161. Mattson M.P., Zhang Y., and Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121 (1993) 1-13
162. Mattson M.P., Kumar K., Cheng B., Wang H., and Michaelis E.K. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein that mediates calcium influx and neurotoxicity in cultured hippocampal neurons. J. Neurosci. 13 (1993) 4575-4588
163. Mattson M.P., Tomaselli K., and Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621 (1993) 35-49
164. Mattson M.P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10 (1993) 243-254
165. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., and Rydel R.E. β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16 (1993) 409-415
166. 2+]i and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65 (1995) 1740-1751
167. Mattson M.P., Barger S.W., Furukawa K., Bruce A.J., Wyss-Coray T., Mark R.J., and Mucke L. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res. Rev. 23 (1996) 47-61
168. Mattson M.P., Furukawa K., Bruce A.J., Mark R.J., and Blanc E.M. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In: Tanzi R.E., and Wasco W. (Eds). Molecular Models of Dementia (1996), Humana Press, Totowa, NJ 103-143
169. McEwen B.S. Steroid hormone actions on the brain: when is the genome involved?. Horm. Behav. 28 (1994) 396-405
170. Meier-Ruge W., Bertoni-Freddari C., and Iwangoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 40 (1994) 246-252
171. Merlio J.P., Emfors P., Kokaia Z., Middlemas D.S., Bengzon J., Kokaia M., Smith M.L., Siesjo B.K., Hunter T., Lindvall O., and Persson H. Increased production of the TrkB protein tyrosine kinase receptor after brain insults. Neuron 10 (1993) 151-164
172. Minami M., Kuraishi Y., and Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNFα and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176 (1991) 593-598
173. Miyazono K., Dijke P., Yamashita H., and Heldin C.H. Signal transduction via serine/threonine kinase receptors. Semin. Cell Biol. 5 (1994) 389-398
174. Mohammed A.H., Henriksson B.G., Soderstrom S., Ebendal T., Olsson T., and Seckl J.R. Environmental influences on the central nervous system and their implications for the aging rat. Behav. Brain Res. 57 (1993) 183-191
175. Morrison R.S. Fibroblast growth factors: potential neurotrophic agents in the central nervous system. J. Neurosci. Res. 17 (1987) 99-101
176. Mufson E.J., and Kordower J.H. Nerve growth factor and its receptors in the primate forebrain: alterations in Alzheimer's disease and potential use in experimental therapeutics. In: Mattson M.P. (Ed). Neuroprotective Signal Transduction (1997), Humana Press, Totowa, NJ in press
177. Mullan M., and Crawford F. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16 (1993) 398-403
178. Nakao N., Kokaia Z., Odin P., and Lindvall O. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp. Neurol. 131 (1995) 1-10
179. Narisawa-Saito M., and Nawa H. Differential regulation of hippocampal neurotrophins during aging in rats. J. Neurochem. 67 (1996) 1124-1131
180. Neeper, S. A., Gomez-Pinilla, F., Choi, J. & Cotman, C. W. (1996). Physical activity increases mRNA for brain derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. in press.
181. Nishida E., and Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18 (1993) 128-131
182. Nistico G., Ciriolo M.R., Fiskin K., Iannone M., De Martino A., and Rotilio G. NGF restores decrease in catalase and increases glutathione peroxidase activity in the brain of aged rats. Neurosci. Lett. 130 (1991) 117-119
183. Nitta, A., Furukawa, S., & Nabeshima, T. (1997). Clinical potential of compounds that stimulate nerve growth factor production. In: Neuroprotective Signal Transduction (Mattson, M. P., ed.). Humana Press, Totowa, NJ, in press.
184. Nixon R.A., Saito K.I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., and Beermann M. Calcium-activated neutral proteinase (calpain). system in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 747 (1994) 77-91
185. Noguchi T., Kurata L., and Sugisaki T. Presence of somatomedin-C-immunoreactive substance in the central nervous system: immunohistochemical mapping studies. J. Neuroendocrinol. 46 (1987) 277-282
186. Nozaki K., Finklestein S.P., and Beal M.F. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J. Cereb. Blood Flow Metab. 13 (1993) 221-228
187. O'Dell T.J., Kandel E.R., and Grant S.G. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 353 (1991) 558-560
188. Olson L. NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124 (1993) 5-15
189. Othberg A., Odin P., Ballagi A., Ahgren A., Funa K., and Lindvall O. Specific effects of platelet derived growth factor (PDGF). on fetal rat and human dopaminergic neurons in vitro. Exp. Brain Res. 105 (1995) 111-122
190. Otto D., and Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10 (1990) 1912-1921
191. Patterson S.L., Grover L.M., Schwartzkroin P.A., and Bothwell M. Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 9 (1992) 1081-1088
192. Patterson D., Warner H.R., Fox L.M., and Rahmani Z. Superoxide dismutase, oxygen radical metabolism, and amyotrophic lateral sclerosis. Mol. Genet. Med. 4 (1994) 79-118
193. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., and Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16 (1996) 1137-1145
194. Pettmann B., Labourdette G., Weibel M., and Sensenbrenner M. The brain fibroblast growth factor (FGF). is localized in neurons. Neurosci. Lett. 68 (1986) 175-180
195. Phillips H.S., Hains J.M., Laramee G.R., Rosenthal A., and Winslow J.W. Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons. Science 250 (1990) 290-294
196. Phillips H.S., Hains J.M., Armanini M., Laramee G., Johnson S.A., and Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7 (1991) 695-702
197. Prakash N., Cohen-Cory S., and Frostig R.D. Rapid and opposite effects of BDNF and NGF on the functional organization of the adult cortex in vivo. Nature 381 (1996) 702-706
198. Prehn J.H.M., Backhaub C., and Krieglstein J. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13 (1993) 521-525
199. Prehn J.H., Bindokas V.P., Marcuccilli C.J., Krajewski S., Reed J.C., and Miller R.J. Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA. 91 (1994) 12599-12603
200. Pringle N.P., Mudhar H.S., Collarini E.J., and Richardson W.D. PDGF receptors in the rat CNS: during late neurogenesis, PDGF-alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115 (1992) 535-551
201. Rinne J.O. Nigral degeneration in Parkinson's disease. Mov. Disord. 1 (1993) S31-35
202. Roberts G.W., Gentleman S.M., Lynch A., and Graham D.I. βA4 amyloid protein deposition in brain after head injury. Lancet 338 (1991) 1422-1423
203. Rocamora N., Welker E., Pascual M., and Soriano E. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. J. Neurosci. 16 (1996) 4411-4419
204. Rothstein J.D., and Kuncl R.W. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65 (1995) 643-651
205. Rothwell N.J., and Hopkins S.J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18 (1995) 130-136
206. Rylett R.J., and Williams L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17 (1994) 486-490
207. Sampath D., Jackson G.R., Werrbach-Perez K., and Perez-Polo J.R. Effects of nerve growth factor on glutathione peroxidase and catalase in PC 12 cells. J. Neurochem. 62 (1994) 2476-2479
208. Sapolsky R.M. Deleterious and salutory effects of steroid hormones in the nervous system: possible mediating cellular mechanisms. In: Mattson M.P. (Ed). Neuroprotective Signal Transduction (1997), Humana Press, Totowa, NJ in press
209. Sasahara M., Fries J.W.U., Raines E.W., Gown A.M., Westrum L.E., Frosch M.P., Bonthron D.T., Ross R., and Collins T. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64 (1991) 217-227
210. Schapira A.H. Oxidative stress in Parkinson's disease. Neuropathol. Appl. Neurobiol. 21 (1995) 3-9
211. Schlessinger J., and Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 9 (1992) 383-391
212. Schumacher J.M., Short M.P., Hyman B.T., Breakefield X.O., and Isacson O. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45 (1991) 561-570
213. Scott S.A., and Crutcher K.A. Nerve growth factor and Alzheimer's disease. Rev. Neurosci. 5 (1994) 179-211
214. Scott S.A., Mufson E.J., Weingartner J.A., Skau K.A., and Crutcher K.A. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15 (1995) 6213-6221
215. Selkoe D.J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10 (1994) 373-403
216. Shelton D.L., and Reichardt L.F. Studies on the expression of the beta nerve growth factor (NGF). gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc. Natl. Acad. Sci. USA. 83 (1986) 2714-2718
217. Shigeno T., Mima T., Takakura K., Graham D.I., Kato G., Hashimoto Y., and Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11 (1991) 2914-2919
218. Shimohama S., and Matsushima H. Signal transduction mechanisms in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9 (1995) 15-22
219. Shimohama S., Ogawa N., Tamura Y., Akaike A., Tsukahara T., Iwata H., and Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res. 32 (1993) 296-302
220. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S., and Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett. 164 (1993) 55-58
221. Siman R., Card J.P., Nelson R.B., and Davis L.G. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3 (1989) 275-285
222. Simpkins J.W., Singh M., and Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging 15 (1994) S195-S197
223. Singh M., Meyer E.M., and Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger RNA expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology. 136 (1995) 2320-2324
224. Smith C.A., Farrah T., and Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76 (1994) 959-962
225. Smith M.A., Sayre L.M., Monnier V.M., and Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18 (1995) 172-176
226. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., and Mattson M.P. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63 (1994) 781-784
227. Smith-Swintosky V.L., Kraemer P.J., Bruce A.J., McCants N., Maki A., Brown R.W., Alcala M., Goodman Y., Slevin J.T., and Mattson M.P. Bacterial alkaloids mitigate seizure-induced hippocampal damage and memory deficits. Exp. Neurol. 141 (1996) 287-296
228. Sohal R.S., Agarwal S., Candas M., Forster M.J., and Lai H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76 (1994) 215-224
229. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., and Lai H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev. 74 (1994) 121-133
230. Speliotes E.K., Caday C.G., Do T., Weise J., Kowall N.W., and Finklestein S.P. Increased expression of basic fibroblast growth factor following focal cerebral infarction in the rat. Mol. Brain Res. 39 (1996) 31-42
231. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., and Hyman C. Brain-derived neurotropic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59 (1992) 99-106
232. Springer J.E., Gwag B.J., and Sessler F.M. Neurotrophic factor mRNA expression in dentate gyrus is increased following in vivo stimulation of the angular bundle. Brain Res. 23 (1994) 135-143
233. Stein-Behrens B., Mattson M.P., Chang I., Yeh M., and Sapolsky R.M. Stress excacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14 (1994) 5373-5380
234. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
235. Tchelingerian J.L., Quinonero J., Booss J., and Jacque C. Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surbical injury to the hippocampus. Neuron 10 (1993) 213-224
236. Terlau H., and Seifert W. Fibroblast growth factor enhances long-term potentiation in the hippocampal slice. Eur. J. Neurosci. 2 (1990) 973-977
237. Thoenen H. Neurotrophins and neuronal plasticity. Science 270 (1995) 593-598
238. Thomas K.A. Biochemistry and molecular biology of fibroblast growth factors. In: Loughlin S.E., and Fallon J.H. (Eds). Neurotrophic Factors (1993), Academic Press, San Diego 285-312
239. Timpe L.C., and Fantl W.J. Modulation of a voltage-activated potassium channel by peptide growth factor receptors. J. Neurosci. 14 (1994) 1195-1201
240. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., and Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373 (1995) 335-339
241. Tooyama I. Fibroblast growth factors (FGFs). in neurodegenerative disorders. Rinsho Shinkeigaku 33 (1993) 1270-1274
242. Tuszynski M.H., Sang H., Yoshida K., and Gage F.H. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30 (1991) 625-636
243. Undie A.S., and Friedman E. Diet restriction prevents aging-induced deficits in brain phosphoinositide metabolism. J. Gerontol. 48 (1993) B62-67
244. Unsicker K. Growth factors in Parkinson's disease. Prog. Growth Factor Res. 5 (1994) 73-87
245. van der Wal E.A., Gomez-Pinilla F., and Cotman C.W. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. NeuroReport 4 (1993) 69-72
246. Ventimiglia R., Mather P.E., Jones B.E., and Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7 (1995) 213-222
247. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., and Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380 (1996) 75-79
248. Vogels O.J., Broere C.A., ter Laak H.J., ten Donkelaar H.J., Nieuwenhuys R., and Schulte B.P. Cell loss and shrinkage in the nucleus basal is Meynert complex in Alzheimer's disease. Neurobiol. Aging 11 (1990) 3-13
249. Walicke P., Cowan W.M., Ueno N., Baird A., and Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and promotes neurite extension. Proc. Natl. Acad. Sci. USA 83 (1986) 3012-3016
250. Wang X., Yue T.-L., White R.F., Barone F.C., and Feuerstein G.Z. Transforming growth factor-β1 exhibits delayed gene expression following focal cerebral ischemia. Brain Res. Bull. 36 (1995) 607-609
251. Watson B.D., and Ginsberg M.D. Ischemic injury in the brain. Role of oxygen radical-mediated processes. Ann. N. Y. Acad. Sci. 559 (1989) 269-281
252. Weiler I.J., Hawrylak N., and Greenough W.T. Morphogenesis in memory formation: synaptic and cellular mechanisms. Behav. Brain Res. 66 (1995) 1-6
253. Weindruch R. Caloric restriction and aging. Scientific Amer. (1996) 46-52
254. Wen T.C., Matsuda S., Yoshimura H., Kawabe T., and Sakanaka M. Ciliary neurotrophic factor prevents ischemia-induced learning disability and neuronal loss in gerbils. Neurosci. Lett. 191 (1995) 55-58
255. Werner M.H., Nanney L.B., Stoscheck C.M., and King L.E. Localization of immunoreactive epidermal growth factor receptors in human nervous system. J. Histochem. Cytochem. 36 (1988) 81-86
256. Williams L.R. Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment. Cerebrovasc. Brain Metab. Rev. 7 (1995) 55-73
257. Williams L.R., Varon S., Peterson G.M., Wictorin K., Fischer W., Björklund A., and Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbriafomix transection. Proc. Natl. Acad. Sci. USA 83 (1986) 9231-9235
258. Wong G.H. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta 1271 (1995) 205-209
259. Yamamoto S., Yoshimine T., Fujita T., Kuroda R., Irie T., Fujioka K., and Hayakawa J. Protective effect of NGF collagen mini-pellet on the hippocampal delayed neuronal death in gerbils. Neurosci. Lett. 141 (1992) 161-165
260. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
261. Zafra F., Hengerer B., Leibrock J., Thoenen H., and Lindholm D. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 9 (1990) 3545-3550
262. Zafra F., Lindholm D., Castren E., Hartikka J., and Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J. Neurosci. 12 (1992) 4793-4799
263. Zhang Y., Tatsuno T., Carney J., and Mattson M.P. Basic FGF, NGF, and IGFs protect hippocampal neurons against iron-induced degeneration. J. Cerebr. Blood Flow Metab. 13 (1993) 378-388